Company / Revenue per Share
Roivant Sciences Revenue per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue per Share
$0.05
FY2025
5-year range
$0.04 / $0.08
FY2021-FY2025
Trend
+30.5%
vs FY2024
Sector context
#141 of 154
Health Care
What the data says
Among 154 Health Care companies, Roivant Sciences is in the bottom 8% for revenue per share. Revenue per Share has fluctuated over the past 6 years, ranging from $0.04 in FY2024 to $0.08 in FY2021.
Based on SEC 10-K filings.
0.05 in FY2025 with a 5-year CAGR of +4.5%.
Improved from $0.04 to $0.05 over the past 2 years.
Health Care sector context is included.
Revenue per Share over time
Growth rates
- 3-Year CAGR
- +8.8%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 154This company $0.05 Sector average $10.35
▼
-99.5% below sector average
Key checks
Key Insights
- In FY2025, revenue per share increased 30.5% year-over-year.
- Ranks #141 out of 154 companies in the Health Care sector.
- Peak revenue per share was recorded in FY2021.
- Lowest revenue per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Revenue per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.05 | +30.5% |
| FY2024 | $0.04 | -16.3% |
| FY2023 | $0.04 | +17.8% |
| FY2022 | $0.04 | -55.8% |
| FY2021 | $0.08 | +118.6% |
| FY2020 | $0.04 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026